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Abstract Technology is advancing at an extraordinary rate. Continuous flows of novel data are being generated with the potential 
to revolutionize how we better identify, treat, manage, and prevent disease across therapeutic areas. However, lack of security of 
confidence in digital health technologies is hampering adoption, particularly for biometric monitoring technologies (BioMeTs) 
where frontline healthcare professionals are struggling to determine which BioMeTs are fit-for-purpose and in which context. 
Here, we discuss the challenges to adoption and offer pragmatic guidance regarding BioMeTs, cumulating in a proposed 
framework to advance their development and deployment in healthcare, health research, and health promotion. Furthermore, the 
framework proposes a process to establish an audit trail of BioMeTs (hardware and algorithms), to instill trust amongst 
multidisciplinary users. 
 
Index Terms— Digital health technologies; Healthcare challenges; Technology management; Research and development; Wearable 
sensors. 
 
I. INTRODUCTION 
DVANCES in technologies are driving the development of low-cost, scalable digital solutions in modern medicine. Of 
course, not all technologies are created equal and a paucity of suitable guidance on how to make selections based on 
predefined clinical requirements is creating a bottleneck in the adoption of digital approaches in medicine; it is often difficult to 
know which product would be fit-for-purpose [1]. To date, there are a plethora of technologies available to healthcare 
professionals to monitor and track a range of biomedical data, outside of the clinic making them advantageous to study more 
habitual behavior’s and/or conditions due to a variety of different environmental contexts.  
Biometric monitoring technologies (BioMeTs) are defined as connected digital medicine tools, processing data captured by 
mobile sensors using algorithms to generate measures of behavioral and/or physiological function [2]. BioMeTs capture person-
specific data yielding objective digital measures that quantify human function to better monitor health and disease and enable 
digital phenotyping for enhancing clinical diagnosis [3]. Although there now appears to be a significant interest in the use of 
BioMeTs in research [4] they are not yet routinely used in clinical practice for many reasons such as usability, security and data 
privacy/governance issues as well as ongoing concerns about how to evaluate their quality (i.e. fit-for-purpose) and safety. The 
latter is the focus of this paper.  
To enhance evaluation capabilities and promote the adoption of safe and effective digitally-collected measures, we: (i) discuss 
the rise of BioMeTs in digital medicine, as well as challenges and efforts to promote adoption; and (ii) propose a standardized 
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BioMeT and algorithm evaluation framework (based on a software reference architecture approach) to overcome challenges in 
the field. The evaluation framework suggests procedures to advocate transparent approaches for BioMeT and algorithms.  
 
II. CHALLENGE 
A. BioMeT and algorithm challenges 
BioMeTs and their corresponding algorithms are often created without expert guidance, disseminated and updated with a lack 
of transparency. Patients and care partners increasingly use mobile technologies, apps and social media  to research information, 
identify treatment options and self-diagnose [5]. Consequently, health professionals are susceptible to increased pressures and 
demand based on technologies they may have limited knowledge of or experience using. There is a need to support knowledge 
exchange across a range of expertise and pragmatic tools to help guide clinical staff to make well-informed decisions, select 
appropriate BioMeTs (based on those that are fit-for-purpose [2]), thereby ensuring patient safety. 
B. BioMeT and algorithm potential 
BioMeTs can generate a variety of digital assessments spanning a broad range of diagnostic and prognostic measures, e.g. 
blood pressure readings to identify hypertension and reduced gait quality from accelerometry for fall prediction, respectively [6]. 
They offer high-resolution sensor-based data at scale and over time, augmenting traditional endpoints such as increased mortality 
risks [7]. The ability to deploy small, discrete BioMeTs that integrate with mobile platforms/smartphones may afford clinicians 
new insights. For instance, BioMeTs can be frequently could/can beyond the clinic, capturing objective free-living digital data 
not previously attainable with questionnaires or self-reported diaries, supplementing subjective opinions and experiences.  
A profound example of how BioMeTs could better manage disease stems from studying motor control within Parkinson’s 
disease. Experts have described a variety of possible uses of inertial sensing BioMeTs in free-living/habitual environments [8]. 
They describe the benefits associated with quantifying walking/gait from high-resolution spatial and temporal data that could 
support a variety of applications including evaluating the efficacy of intervention, optimizing medication dosing, monitoring 
disease progression and cognitive decline [9]. The capture of such pragmatic, patient-specific information performed during 
habitual activities has driven an explosion of interest over the possibility of digital medicine to change how medications (and 
other interventions) are used, adjusted, and evaluated [10]. Here, we focus on inertial-based BioMeTs only as the inclusion of all 
types of devices would be beyond the scope of one paper. 
C. Inertial-based BioMeT and algorithm gaps 
Many current clinical endpoints inadequately reflect patient burden compared to digital endpoints, the latter described as new 
armamentarium offering continuous rather than snapshot assessments [7]. However, the promise of BioMeTs is accompanied by a 
wave of algorithms and associated digital measures that are difficult to understand or evaluate in comparison to traditional 
outcomes. Some BioMeTs are clinically more intuitive than others, such as an instrumented approach to a timed-up-and-go test or 
total distance walked [11] and offer additional insights to traditional assessments under observation. Others, such as refined 
composite multiscale entropy measured during daily walking are not immediately translatable into current clinical practice despite 
showing value in assessing fall risk in older adults [12]. Yet, given the breadth of inertial-based BioMeTs and body attachment 
locations, there is little consensus on the exact algorithm and/or quantifiable measure that should be used for disease subtypes. 
III. CLINICAL IMPACT 
In addition to the notable efforts and resources (section III) to offer insight to digital approaches in healthcare there are 
approaches to implement standardized reporting that are championed by scientific journals1. However, all are not appropriate to 
evaluate digital-based BioMeTs or algorithms where multidisciplinary teams focus on different performance aspects of the 
technology. Here, we propose a framework based on a reference architecture which aims to be accessible to a variety of 
disciplines to ensure BioMeTs and their algorithms are adequately and transparently developed and understood. This involves a 
need to streamline BioMeT and algorithm development to aid more unified innovation and robust application in clinical cohorts. 
Given the prevalence of BioMeTs entering medical research, the general ease with which component algorithms can be created 
(often without scrutiny) and the wide professional interest in their use, bespoke guidance for a multidisciplinary audience is 
desperately needed. This could be achieved by creating a set of professionally tailored standardized guidelines and support 
mechanisms to ensure BioMeTs and algorithms are better understood and used appropriately within and across populations. 
Additionally, there is a need to track and trace (from engineering or computer science-based development through to clinical 
application) as well as improve the transparency of BioMeT and algorithms. 
 
1www.biomedcentral.com/getpublished/editorial-policies#standards+of+reporting 
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IV. STATE-OF-THE-ART 
Efforts to guide the creation, measurement, and evaluation of clinically meaningful outcomes are demonstrated by initiatives 
such as COMET (Core Outcome Measures in Effectiveness Trials): aiming to standardize core outcome sets across a wide range 
of health topics, representing the minimum that should be measured and reported in clinical trials for specific conditions [13].  
Other generic sources/tools exist to help navigate the plethora of BioMeTs by providing general insights to functionality, e.g. 
Scripps Research Translational Institute open database of commercial products [14] and the National Health Service list of 
applications/apps to manage and improve health [15]. Yet, these sources lack information and expert guidance on 
verification/validation protocols for accurate and robust use. Other more appropriate and targeted information is found elsewhere. 
For example, the Clinical Trials Transformation Initiative (CTTI), co-founded by Duke University and the Food and Drug 
Administration (FDA), developed an open live database of feasibility studies to promote effective use of mobile technologies in 
clinical research to avoid duplication of existing research [16]. A non-exhaustive list of some current organizations and their 
resources to guide digital efforts in medicine are presented, grouped according to organization type, e.g. regulatory, non-profit, 
commercial, etc.: 
• Clinical Trials Transformation Initiative (search Mobile Technologies): Develops and drives adoption of practices that will 
increase the quality and efficiency of clinical trials www.ctti-clinicaltrials.org  
• WHO: 
o Digital Health Atlas: Global technology registry platform aiming to strengthen the value and impact of digital health 
investment https://digitalhealthatlas.org 
o Monitoring & Evaluation of Digital Health handbook: https://tinyurl.com/rrc2zny  
• FDA (specifically: Medical Devices / Digital Health): Seeks to better protect and promote public health and provide continued 
regulatory clarity www.fda.gov 
• National Health Service (NHS) Apps Library: Recommended Apps and tools to manage health and wellbeing 
www.nhs.uk/apps-library 
• NICE (Evidence standards framework for digital health technologies): To make it easier for innovators and commissioners to 
understand what good levels of evidence for digital healthcare technologies look like www.nice.org.uk 
• COMET: Development and application of agreed standardised sets of outcomes www.comet-initiative.org  
• Equator Network: Seeks to improve the reliability and value of published health research literature www.equator-network.org 
• Open mHealth: Global community of developers and health tech decision makers to help make sense of digital health data 
through an open interoperability standard www.openmhealth.org 
• Open Wearables Initiative: Collaboration designed to promote the effective use of high-quality, sensor-generated measures of 
health in clinical research through the open sharing of algorithms and data sets.  www.owear.org  
• RANKED Health: Run by the Hacking Medicine Institute (HMi, a non-profit organization spun out of MIT’s Hacking 
Medicine program). This project is designed to review and rank healthcare focused applications www.rankedhealth.com 
• Digital Therapeutics Alliance (DTA): Evidence-driven advancement of digital therapeutics with an industrial focus 
www.dtxalliance.org 
• Digital Medicine Society (DiMe): Supports development of digital medicine through interdisciplinary collaboration, research, 
teaching, and the promotion of best practices  http://dimesociety.org 
• Elektra Labs: Advances remote patient phenotypic monitoring by enabling the safe and effective use of connected biosensors at 
home https://elektralabs.com  
• Fair Sharing: Resource on data and metadata standards, inter-related to databases and data policies http://fairsharing.org 
• Fitabase: Enable researchers to use the latest tools, devices, and apps to making it as easy as possible for researchers to 
measure, track, and engage participants www.fitabase.com  
• NODE.Health: Evidence based digital medicine that brings together a network of societies, regulators, organizations and 
innovators https://nodehealth.org 
• Personal Connected Health Alliance: Aims to advance patient/consumer-centered health, wellness and disease prevention 
www.pchalliance.org 
• ReCODE: Set of policy recommendations for facilitating open access to research data www.dhi.ac.uk/recode/ 
• Scripps Research Translational Institute library: A resource for researchers and other stakeholders to learn about tools they 
might consider utilizing in health-related research or clinical practice https://digitalhealthlibrary.scripps.edu 
• SMART Health IT: Previously proposed a universal API (application programming interface) to transform EHRs into 
platforms for substitutable iPhone-like apps https://smarthealthit.org 
• Wellocracy: Information on new personal self-health technologies like activity trackers, wireless devices and mobile apps 
www.wellocracy.com 
Although efforts by these organizations are useful, future work must link engineering and computer science-based studies and 
developments with clinical trials that adopt the same technology as well as provide information regarding the successful use of 
 
 
BioMeTs in drug approval and/or use in clinical practice. More specifically, structured evaluation frameworks are critical to 
ensure that ‘going digital’ will be a more trustworthy process, avoiding unnecessary barriers to technology adoption [2]. 
V. PROPOSED METHODS AND PROCEDURES 
Co-authors hosted a 3-day workshop held in March 2019 (Newcastle, UK) involving a number of professionals from 
complementary disciplines including computing science, biomedical engineering, human-centered design, digital technologies, 
clinical and social sciences. Prior to the workshop, a scoping review of BioMeT literature was performed by attendees and used 
for points of framework synthesis discussion. When constructing the framework, a hybrid design approach was adopted [17] 
which emphasized the involvement of future end users expertise and experiences primarily for (i) the design and (ii) translational 
understanding and use of BioMeTs and algorithms in a clinical setting. Similar to other work in the field to evaluate measurement 
technologies [1], the approach adopted here was deemed most appropriate considering the multidisciplinary nature of BioMeT 
and algorithm research which requires input from a range of expertise in the field. Other collaborators from industry were later 
involved to ensure the framework proposed here aligned to current validation and verification initiatives [2]. 
Specifically, we set out to define a BioMeT and algorithm conceptual framework for a congruent reference architecture [18] to 
achieve the following aim:  
I. To create a ‘‘tool’’ based on the design of congruent reference architectures to standardize and evaluate BioMeTs and their 
algorithms, 
Once conceptual procedures were ratified, a prototype was developed with the following objectives: 
i. Documentation of technical specifications;  
ii. Ensure fit-for-purpose by creating transparency;  
iii. Clarify verification and validation procedures and;  
iv. Produce digital trails of BioMeTs and algorithms, so they may be tracked from development through to deployment for 
coherent and appropriate use.  
Qualitative feedback on framework prototype design and functionality was acquired from healthcare professionals and 
computer scientists with experience of BioMeT use and algorithm development in older adult cohorts. The Faculty of 
Engineering and Environment, Northumbria University research ethics committee granted ethical approval (Ref: 9203). 
Participants gave written informed consent, agreeing to anonymized direct quotes being presented in this text. 
A. Workshop scoping analysis 
Given the scoping review prior to the workshop it was found that current pragmatic resources to openly evaluate BioMeT and 
their algorithms are sparse. Although many are described in academic literature (and other online media), there are no 
standardized evaluation resources to direct how BioMeTs and algorithms are should be tested, verified, and validated according 
to expertly guided criteria with specific details of how each level of testing, verification and validation is performed. This 
includes but is not limited to robust data capturing protocols and statistical guidance. Additionally, no consideration is given to 
optimize the dissemination or evaluations of algorithms to the diverse, multidisciplinary audience utilizing them for pragmatic 
adoption. Current inconsistencies include algorithms reported in engineering-based pilot and feasibility studies for one cohort 
(e.g. younger adults) that are later used in a different cohort (e.g. older adults with stroke) where BioMeTs or algorithms may be 
unsuitable. Furthermore, discussion arising from the workshop highlighted three important implementation procedures to 
formulate the development of a robust conceptual framework: (1) clarity pertaining to BioMeT and algorithm descriptions, (2) 
audit trails (mapping) and (3) multidisciplinary approaches.  
B. Procedure 1: BioMeT and algorithm descriptions 
It was concluded that BioMeT and algorithm evaluation procedures proposed as part of the framework should be informed by 
extensive literature searches to ensure a rounded, well-informed and expert creation. This should be achieved by performing 
systematic reviews which target specific areas of BioMeT/algorithm development (e.g. inertial unit with accelerometers) and 
deployment (e.g. measuring gait). Systematically reviewing the literature within therapeutic areas should help categorize the 
range of BioMeTs and algorithms to quantify measures of interest for specific diseases. To categorize and prioritize findings from 
reviews, a Delphi method – an iterative process of expert review and feedback – should be used to identify the most appropriate 
details/content that should be known about a BioMeT and/or algorithm for inclusion on the framework, facilitating standardized 
testing protocols relating to expertly agreed verification, analytical validation and clinical validation procedures. It was argued 
that developing the framework in this way would ensure that details which are often lacking in peer reviewed literature – perhaps 
due to heterogeneity in reviewer experience and journal requirements/aims – are routinely identified and reported. This would 
ensure a well-informed, standardized evaluation and transparent reporting of details, yielding greater clarity on how and where 
BioMeTs should be used as well as limitations of their algorithms across various cohorts in different environmental conditions. 
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C. Procedure 2: Digital audit trails and mapping 
It was deemed important that the framework provide mechanisms to register and track BioMeTs and algorithms through 
development and implementation. Currently, development of BioMeTs and their constituent algorithms cannot be robustly 
tracked across the literature. Often the only viable option is to thrall through references, locating and backtrack within the 
literature to find how and where BioMeTs and/or algorithms have been created and used. However, although some engineers are 
now adopting computer science-based approaches and placing code/algorithm online via open platforms (e.g. GitHub) this may 
still be a barrier for healthcare professionals who may struggle to engage with such a platform and/or be unsure about the 
implementation of code on BioMeT data. Specifically, for those unfamiliar with the field this is difficult and quite often 
pragmatic challenges exist such as access to relevant journal papers, which is a major limitation in developing economies. 
Moreover, slight variations in algorithms (e.g. thresholds) may often go unnoticed or unreported and there is often little detail or 
explanation as to why these occur. Implementing a framework that (i) assigns a unique identifier number to BioMeTs (its 
constituent sensors) and/or algorithms, and (ii) provide a mechanism to dynamically consider hardware or software updates 
would greatly help understanding and robust deployment. Such an approach would facilitate a central repository of BioMeTs and 
algorithms with an ability to track their development (version control), providing a digital audit trail useful for data scientists and 
clinicians alike.  
Additionally, a mechanism to map the use of BioMeTs and algorithms was deemed necessary. Such functionality would list 
(map) where the technology has been used e.g. validation and later applied in cohorts. Such an approach would help clarify if 
appropriate validation procedures have been conducted for each cohort and allude to BioMeT/algorithm generalizability.  
D. Procedure 3: Multidisciplinary functionality 
The proposed framework aims to satisfy a range of research questions from diverse disciplines. In the first instance data 
scientists could use the framework to upload details of a BioMeT/algorithm based on a predefined set of questions (e.g. what 
make and model of accelerometer or what language was used to write the algorithm?). These questions would be developed 
through a separate Delphi processes for each field of research. When a new BioMeT or algorithm is entered into the framework, a 
new ID will be allocated. Updates to pre-existing BioMeTs and/or algorithms will be recorded as such. After details relating to 
protocols are entered, the algorithm will be uploaded and tested. If the algorithm is unique where no anonymized data exists in 
the framework, any data used by the engineer to develop the algorithm will be sought and required for upload also. Given said 
data may be limited to one/two test subjects, the framework’s administration team would collect independent data while also 
encouraging the research community to gather their own and contribute. Testing of algorithms and data should occur in a digital 
sandpit against the (read-only) reference data held by the framework to compare its accuracy against other similar algorithms 
and/or to its previous version (if applicable). The sandpit should provide some interactive functionality whereby the data scientist 
can manipulate his/her code to test new assumptions on the fly. Once testing is complete, the algorithm will be submitted to the 
framework administrators for final checking and later publishing to all framework users. 
Clinical experts would experience more limited access to the framework. They should be able to search by therapeutic area or 
technology type and compare BioMeTs and algorithms. This will support selection of the most fit-for-purpose BioMeT. 
E. Development, adherence and impact 
It was noted by workshop attendees that to populate and maintain the framework as a living resource, it should mimic existing 
efforts for registering and tracking research outputs (e.g. www.crd.york.ac.uk/PROSPERO). This will ensure the scientific 
community is aware of the framework as a useful “go-to-tool”. 
VI. RESULTS 
The proposed conceptual evaluation framework (design) details a digital interaction experience specifically tailored for 
differing professions who design/develop/create or use BioMeTs and/or their algorithms, i.e. engineers or data scientists and 
healthcare professionals, respectively (Fig. 1). Here, the framework is named the BioMeT Registry (Fig. 1 and 2) to highlight an 
objective, i.e. documentation of technical specifications. 
 
 
 
Key to the successful creation and implementation of the framework is a robust administrative project management software 
layer (Fig 1-i) informed by systematic reviews and Delphi processes. Implementation of this layer will ensure robust iterative 
development, i.e. a procedure to broaden the framework to numerous areas of BioMeT development and application. For 
example, it was proposed by workshop delegates that the first iteration of the framework be created to harmonize and standardize 
inertial sensor-based BioMeTs and their quantification of gait/walking as that topic has shown particular pragmatic data capture 
in recent years for neurological cohorts (section II-B). Once initiated, the same methodologies (i.e. systematic review and Delphi 
process) could be used in other BioMeT areas of interest, e.g. electrocardiogram in coronary disease.
 
 
 
Fig. 1.  Framework title page. Tailored experience to (i) engineer (or data scientist) and (ii) clinician (healthcare professional), This dual engagement is a key 
feature to ensure widespread applicability to multidisciplinary users. 
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Figure 1 Proposed conceptual framework (left to right, top to bottom): 
(i) The framework should be informed by comprehensive systematic reviews from the literature in different therapeutic areas to inform dedicated 
BioMeT and algorithm development work in each pathology (Procedure 1). This work should extract e.g. digital measures and protocols to inform a 
Delphi process of expert agreement in each area to define appropriate evaluation standards, i.e. what measure and protocol should be quantified and 
used when creating new algorithms in a specific patient cohort. Algorithms should be accompanied by a selection of data used in their 
creation/design which could serve as a mechanism for other algorithms to be tested, useful for those with no resources to acquire participant data.  
(ii) The core functionality of the framework should align to multidisciplinary use with interactive features (Procedure 3).  
(iii) E.g. a healthcare professional registers and searches algorithms based on measurement of interest (e.g. gait) and views reports on how data were 
collected to verify and validate a gait algorithm. 
(iv) Engineers or data scientists should register and specify what pathology their BioMeT aligns to and what digital measurement it aims to quantify. 
New BioMeTs and algorithms should be assigned a unique identifier number (ID*) to tracking across the literature, providing an audit trail, 
Procedure 2. The framework could provide an interactive online sandpit to test algorithms, generating comparative results to other known algorithms 
in the field (Appendix A). 
(v) A digital audit trail would be useful to track BioMeTs and algorithms from areas of development (e.g. engineering) to application (e.g. health 
sciences), Procedure 2. 
*ID could also be a mechanism to track iterative improvements in any algorithm should it be updated across the literature 
 
 
 
A. Transparency and tracking 
Procedures 1 to 3 are implemented to register, test, compare and track development and performance of BioMeTs and 
algorithms (Fig. 3). Such functionality should be observable from the engineering or clinical iterative perspective (Fig 1). 
Additionally, mapping and examining how and where BioMeTs and/or algorithms have been used across the literature is key, 
from engineering development to clinical application. All evaluation frameworks should support a digital trail to see if the 
technology has been developed and deployed in an appropriate manner (Fig. 3) and where it has been used (Fig. 4). For a full 
user flow experience please see appendices. 
 
 
 
B. Prototype discussion 
Qualitative feedback on framework prototype and general functionality for use to overcome challenges in the field was acquired 
from healthcare professionals (n=2) and computer scientists (n=2) with experience of BioMeT use and algorithm development in 
older adult cohorts. Users were presented with a description of the prototype, what it aimed to achieve and left to interact with it. 
A brief discussion captured user comments. In general, users indicated that the framework would “provide a very useful 
technique to examine wearables [BioMeTs] and to see where they have been used in one collective interface”. One user liked the 
transparency of the framework but raised interesting insights, explaining that “although the framework would be insightful, I 
doubt a typical clinician would understand how algorithms would function based on brief descriptions or code [algorithm 
scripts] displays”. This raised an interesting point for discussion pertaining to the framework as an educational platform to offer 
the less technical user added insight to grasp the fundamentals of BioMeT/algorithm functionality. Upon further discussion, the 
user described a current online platform (www.codecademy.com) as one example that the framework/registry could draw 
inspiration from to implement a more focused translational learning experience. It was agreed that although useful, that would be 
 
Fig 4. Mapping BioMeTs and algorithms used across the literature. 
 
Fig 3. Key implementation framework characteristics include 
transparent registering of the algorithm (left) before examining 
accuracy results to other similar BioMeTs or algorithms within the 
same therapeutic area (top right). Any iterative BioMeT or algorithm 
improvements would also be recorded to see how technical 
adjustments aided increased accuracies (audit trail of 
BioMeT/algorithm, bottom right). 
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beyond the scope of initial framework development and would require more tailored engagement from BioMeT and algorithm 
developers by adding more bespoke learning material upon registration. 
Users praised version control aspects of the framework (Fig. 3, History) and spoke of similarities to GitHub. Certainly, the 
latter is becoming more popular with BioMeT and algorithm developers as the field moves towards more open methodologies 
[19]. However, simple version control logging representation presented here might “better appeal to those less familiar with code 
repositories”, who “would want simple and clear algorithm accuracy metrics and when they were achieved” (Fig. 3).  
Lastly, implementation of the registry was discussed with notable challenges raised, primarily relating to framework 
administration (Fig. 2i) and scalability. Though it was described to users that the framework/registry should be created on inertial 
sensor BioMeT work for iterative aspects of physical functioning assessment (1. gait, 2. postural control etc), later progressing to 
other technologies for other physiological assessment, reservations were raised. “I think notable resources would be required for a 
single team to implement the registry at scale, given the complexity and time consuming nature of systematic reviews, including 
data extraction, and conducting Delphi exercises”. This raised a fundamental issue about implementing such a complex and 
interactive framework. Indeed, given its multifaceted nature, successful implementation may not be achievable unless significant 
financial resources were leveraged to supply personnel. Alternatively, it was discussed that the research community could look at 
this as an opportunity to harmonize the field and work collaboratively to share resources and responsibilities. Regardless, 
implementation of any such tool should follow methods/procedures proposed here to ensure rigorous approaches. 
VII. FUTURE DIRECTION AND ACTIONS 
Attendees of a multidisciplinary workshop designed a novel framework that considers diverse expertise while implementing 
version control and digital auditing trails for inertial-based BioMeTs. The conceptual framework and resultant registry prototype 
suggests an approach to implementing harmonized and transparent approaches for BioMeT and algorithm development that 
aligns with existing initiatives in digital medicine promoting fit-for-purpose approaches. Implementing this proposed framework 
will be challenging, multifaceted and costly. Therefore, it is suggested that realization of such a clinically relevant and pragmatic 
engineering “tool” may only be feasible if considering a modular approach, i.e. separate groups taking leadership on different 
aspects of BioMeT work (i.e. different types of devices) in different therapeutic areas under the umbrella of this framework and 
its methodological procedures presented here. Moreover, this tool should be considered as one part of the process to ensure 
inertial (and other) BioMeT devices are used suitably as well as securely in healthcare applications. Although not the focus of this 
work, implementation of algorithms and analysis of patient data in applied healthcare applications should also consider best 
practice and expert direction for confidentiality and information security. 
Currently, BioMeTs and their algorithms are being used without undergoing appropriate scrutiny and lacking expert guidance, 
generating heterogeneous and in some cases unvalidated and inaccurate digital measurements. In other cases, they are not being 
used at all as clinicians and technologists are unable to evaluate them. Our proposed framework would greatly help users from 
various backgrounds better understand and use BioMeTs and/or algorithms in the service of improved health, healthcare, and 
health research. The registry (Fig. 2) should be an open resource to implement evaluation standards in the field, ensuring digital 
measures are high quality, safe, effective, and fit-for-purpose.  
APPENDIX 
See online supplementary material, Appendix A. 
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Appendices 
 
1. Welcome to the biometric monitoring technology (BioMeT) registry: 
a. The following is a prototype developed by the authors (2019) with aid from a web design and digital agency 
(Union Room, Newcastle upon Tyne: www.unionroom.com) 
 
2. Engineer / data scientist interaction (here the example details a gait algorithm):  
a. For an engineers or data scientist approach the path from registration should be different, offering more 
interaction. For the engineers approach, initial sign up or login (if returning) 
 
b. Once registered (or returning), the engineer should be able to add his/her algorithm or hardware (BioMeT) 
descriptions: 
 
 
 
c. A predefined sequence of inputs will need to be entered based on what is important to the field of research 
(as defined by a Delphi exercise). 
 
d. Important verification and validation questions will need to be answered for algorithm and/or BioMeT 
transparency 
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e. It would be important to know if the algorithm has been used in previous (published) research, to begin 
linking it to previous studies 
 
f. The onus will be on the person registering the algorithm to identify where the algorithm or BioMeT has been 
used previously in research. However, framework administrators should also be able to retrospectively link 
algorithms and BioMeTs to studies (based on systematic reviews performed for each field of research and 
updated periodically). 
 
 
 
g. Once any algorithm or BioMeT hardware descriptions have been uploaded, the framework should also be able 
to provide a testing bed for engineers who may not have access to patient populations to gather pathology 
specific data. Thus, ground truth data collected by the framework team will be available (but non-
downloadable) for the engineer to test his/her algorithm online. Moreover, this should also facilitate 
anonymised data donations to encourage collaboration and aid algorithm development. 
 
h. The interactive digital sandpit should generate accuracy results for the algorithm, comparing to other similar 
algorithms on the same data for more robust comparison. 
 
i. Once the algorithm has been submitted, all details should be vetted by the framework administration team 
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j. Once checked and approved, the algorithm and all details will be listed for that engineer under their profile. 
Those that have been vetted will receive a “white flag”, those that have not are labelled with a “black flag”, 
which aids healthcare professionals to determine what has been examined by the (independent) framework 
administrators (image 3b, page 6). 
 
3. A clinicians (healthcare professions) interaction: 
a. Alternatively for the healthcare professional (HcP), there should be a different flow through the framework. 
After registration/login, HcP select their area of interest: 
 
 
 
b. The HcP should be able to search algorithms and BioMeTs from those entered into the framework. The 
black/white flag will indicate those that have been entered by engineers or retrospectively by the framework 
administration team 
 
c. The HcP could then examine various algorithm accuracies from implementation on reference data held by the 
framework 
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d. Importantly, the framework should allow the HcP to investigate where the algorithm has been used in 
previous studies (from whatever field) 
 
e. Of equal importance would be the ability to see changes/updates in the algorithm (that will be completed by 
the engineer from their interaction with the framework) 
 
 
***** 
 
